Nuformix plc
Nuformix plc, together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. The company develops NXP001, which is in the Phase 1 stage for use in oncology supportive care; NXP002, which is in the pre-clinical stage for the treatment of idiopathic pulmonary fibrosis… Read more
Nuformix plc (NFX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.296x
Based on the latest financial reports, Nuformix plc (NFX) has a cash flow conversion efficiency ratio of -0.296x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-223.56K) by net assets (GBX754.93K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nuformix plc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Nuformix plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nuformix plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuformix plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fraser Big Sky Capital Corp.
V:FRAS-P
|
N/A |
|
PT Indokripto Koin Semesta Tbk
JK:COIN
|
0.065x |
|
Great American Food Chain Inc. (The)
PINK:GAMN
|
0.006x |
|
BTS Rail Mass Transit Growth
BK:BTSGIF
|
0.029x |
|
Minesto AB (publ)
BE:7MN
|
-0.015x |
|
RED PINE EXPL
F:VG3
|
N/A |
|
KKO INTERNATIONAL EO-10
F:5KI1
|
N/A |
|
Odin for Investment & Development
EGX:ODID
|
N/A |
Annual Cash Flow Conversion Efficiency for Nuformix plc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Nuformix plc from 2014 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX754.93K | GBX-614.61K | -0.814x | -75.53% |
| 2024-09-30 | GBX715.57K | GBX-331.88K | -0.464x | -256.20% |
| 2023-09-30 | GBX4.20 Million | GBX-546.23K | -0.130x | -27.12% |
| 2023-03-31 | GBX4.23 Million | GBX-433.10K | -0.102x | +63.94% |
| 2022-03-31 | GBX4.74 Million | GBX-1.35 Million | -0.284x | -90.40% |
| 2021-03-31 | GBX5.69 Million | GBX-848.22K | -0.149x | +2.77% |
| 2020-03-31 | GBX4.74 Million | GBX-727.60K | -0.153x | -95.54% |
| 2019-03-31 | GBX3.82 Million | GBX-299.34K | -0.078x | +76.98% |
| 2018-03-31 | GBX4.49 Million | GBX-1.53 Million | -0.341x | -112.33% |
| 2017-03-31 | GBX-179.59K | GBX-496.32K | 2.764x | +496.03% |
| 2016-03-31 | GBX502.34K | GBX-350.55K | -0.698x | -89021.82% |
| 2015-07-31 | GBX-110.86K | GBX86.80 | -0.001x | -224.10% |
| 2014-07-31 | GBX247.00K | GBX155.85 | 0.001x | -- |